Australia - English - Department of Health (Therapeutic Goods Administration)

acra regulatory services pty ltd - 63031 - cognitive function interactive software - active brain tracking is a computerized cognitive and functional brain performance assessment aid that provides clinicians with measurements of cognitive and functional brain performance in populations aged 12 to 65 years, to aid in the assessment of an individual's level of cognitive and functional brain performance. it relies on inputs from visual cues, auditory cues, and functional use of the hand. eq active brain tracking should only be used as an adjunctive tool for evaluating cognitive and functional brain performance and is not intended to be used for clinical decision assessment for specific diseases or conditions.

Australia - English - Department of Health (Therapeutic Goods Administration)

acra regulatory services pty ltd - 63185 - cognitive assessment software - the device is intended for use as a computer-based neurocognitive test to aid in the assessment and management of concussion.

Australia - English - Department of Health (Therapeutic Goods Administration)

xrhealth au pty ltd - 63031 - cognitive function interactive software - the vrcogni are a prescription only medical device software applications that provide various vr environments to aid mitigate or assess conditions related to cognitive function by providing cognitive exercises and cognitive ability measurements. the cognitive exercises and cognitive ability measurements rely on inputs from visual and auditory stimuli, and functional use of the hands and enable: ? guiding patients in the performance of various cognitive exercises ? track and analyze motion and movement kinematics ? monitoring changes in patient's measurements over time the vrcogni ct-610 and ct-620 can be used as an assessment aid to determine the level of cognitive function for which there exists other valid methods of cognitive assessment. vrcogni ct-610 and ct-620 are not intended to be used for diagnosis, treatment, decision making, or as a stand-alone device. moreover, they do not identify the presence or absence of clinical diagnoses.

Australia - English - Department of Health (Therapeutic Goods Administration)

compliance management solutions - 63185 - cognitive assessment software - sharp is a software program intended to be used to assess cognitive function, and to assist in early detection of mild cognitive impairment or dementia.

Australia - English - Department of Health (Therapeutic Goods Administration)

think mobility pty ltd - 63031 - cognitive function interactive software - to be used with an off-the-shelf computer/tablet/smartphone to help improve a cognitive function (e.g., attention/concentration, memory, eye movement training to improve reading ability) by providing a patient with on-screen interactive sessions (e.g., text for audible reading); it is not intended to detect/display a patient?s physical movements/actions.

Australia - English - Department of Health (Therapeutic Goods Administration)

neurotek pty ltd - 63031 - cognitive function interactive software - a rehabilitation training program for patients with cognitive impairment helping them recover their cognitive functions.

Australia - English - Department of Health (Therapeutic Goods Administration)

tali health pty ltd - 63031 - cognitive function interactive software - rago is intended to be used as a cognitive trainer available on a tablet to develop cognitive function of attention in children between the ages of 3-10, by playing digitised and gamified tasks under the direction of a healthcare professional. rago is an adjunctive tool and is not intended to be used as a stand-alone diagnostic or screener.

Australia - English - Department of Health (Therapeutic Goods Administration)

fit-bioceuticals pty ltd - panax ginseng, quantity: 70.83 mg (equivalent: panax ginseng, qty 212.5 mg; equivalent: ginsenosides rg1- re- rf- rg2- rb1- rb2- rc- rd (of panax ginseng), qty 4.25 mg); alpha lipoic acid, quantity: 300 mg; ginkgo biloba, quantity: 60 mg; bacopa monnieri, quantity: 200 mg - tablet, film coated - excipient ingredients: carnauba wax; colloidal anhydrous silica; croscarmellose sodium; hypromellose; crospovidone; macrogol 400; chlorophyllin-copper complex; magnesium stearate; povidone; microcrystalline cellulose; calcium hydrogen phosphate dihydrate - antioxidant/reduce free radicals formed in the body ; maintain/support energy production ; maintain/support physical endurance/capacity/stamina ; relieve weariness/tiredness/fatigue/feeling of weakness ; maintain/support healthy blood circulation ; maintain/support blood circulation/flow to the peripheral areas of the body (legs, hands and feet) ; maintain/support cognitive function/mental function ; maintain/support learning and information processing ; maintain/support memory/mental recall

Australia - English - Department of Health (Therapeutic Goods Administration)

xrhealth au pty ltd - 63031 - cognitive function interactive software - the vrreliever software family is intended to assist in relaxation and in the mitigation of pain, hot flashes and physical discomfort through distraction and supporting meditation and relaxation exercises, performed in a virtual reality (vr) environment using commercially available vr headsets. the vrreliever is a nonprescription software family that can be used in clinical setting or at home, with or without the assistance of clinician. the vrreliever provides vr exercises and takes measurements which enables the patient and/or clinician to monitor changes over time. the vrreliever does not provide a report that analyzes the measurements, makes medical diagnoses, or recommends treatment

Australia - English - Department of Health (Therapeutic Goods Administration)

emergo asia pacific pty ltd t/a emergo australia - 63185 - cognitive assessment software - this device provides healthcare professionals with objective measurements of attention and inhibitory control. the visual component aids in the assessment of, and evaluation of treatment for, attention deficits, including attention-deficit/hyperactivity disorder (adhd). the auditory component aids in the assessment of attention deficits, including adhd. results should only be interpreted by qualified professionals.